Cipher Pharmaceuticals Analysis

Cipher Pharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Cipher Pharmaceuticals otc analysis is to determine its intrinsic value, which is an estimate of what Cipher Pharmaceuticals is worth, separate from its market price. There are two main types of Cipher Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Cipher Pharmaceuticals otc stock is traded in the USA on OTCQX Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Cipher Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Cipher OTC Stock Analysis Notes

About 44.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.63. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cipher Pharmaceuticals had not issued any dividends in recent years. Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada. Companhia Siderurgica is traded on OTC Exchange in the United States.The quote for Cipher Pharmaceuticals is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Cipher Pharmaceuticals please contact the company at 905 602 5840 or go to https://www.cipherpharma.com.

Cipher Pharmaceuticals Investment Alerts

Cipher Pharmaceuticals is not yet fully synchronised with the market data
Cipher Pharmaceuticals has some characteristics of a very speculative penny stock
Cipher Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
About 44.0% of the company shares are held by company insiders

Cipher Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 64.32 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cipher Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Cipher Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Cipher Profitablity

Cipher Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Cipher Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Cipher Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Cipher Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Cipher Pharmaceuticals' profitability requires more research than a typical breakdown of Cipher Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.45 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.57 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.57.

Cipher Pharmaceuticals Outstanding Bonds

Cipher Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cipher Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cipher bonds can be classified according to their maturity, which is the date when Cipher Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Cipher Pharmaceuticals to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Price Transformation Now

   

Price Transformation

Use Price Transformation models to analyze the depth of different equity instruments across global markets
All  Next Launch Module
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Consideration for investing in Cipher OTC Stock

If you are still planning to invest in Cipher Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cipher Pharmaceuticals' history and understand the potential risks before investing.
CEOs Directory
Screen CEOs from public companies around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments